Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2021-10-29 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
益丰药房2021年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2021年第三季度报告' which translates to '2021 Third Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on accounting policies. The report covers a specific quarter (third quarter of 2021) and includes unaudited financial statements and management commentary on financial performance and business activities such as acquisitions. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a comprehensive quarterly financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2021
2021-10-29 Chinese
益丰药房关于完成工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from 益丰大药房连锁股份有限公司 regarding the completion of industrial and commercial registration changes, specifically about changes in registered capital and amendments to the company's articles of association. It includes updated company registration details such as the unified social credit code, company name, type, address, legal representative, registered capital, establishment date, business scope, and other administrative information. The document is relatively short (1322 characters) and does not contain financial statements, management discussion, or detailed financial data. It is not a report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory certification or audit report. Instead, it is a formal announcement of a corporate registration update, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-10-07 Chinese
益丰药房高级管理人员集中竞价减持股份计划公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding a planned share reduction by senior management personnel of the company. It details the number of shares held by each executive, the planned amount of shares to be sold, the timing, and the reasons for the sale (personal financial needs). It also includes risk disclosures and compliance statements related to the share reduction. There are no financial statements, earnings data, or report attachments. The content focuses on insider share transactions by company directors and executives. Therefore, this document fits the category of Director's Dealing (DIRS). The document length is 2830 characters, which is consistent with a detailed announcement but not a full financial report.
2021-10-07 Chinese
益丰药房关于使用可转换公司债券闲置募集资金购买理财产品的进展公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from a company about the progress of using idle raised funds from convertible bonds to purchase financial products, specifically structured deposits. It includes detailed financial figures, descriptions of the financial products, risk assessments, internal controls, and approvals from the board and shareholders. The document is not a full financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory announcement about the company's capital management activities related to the use of raised funds. This fits best under the category of Capital/Financing Update (CAP), as it provides updates on the company's use of raised capital and investment activities with those funds. The document length (6844 characters) and content support this classification with high confidence.
2021-09-27 Chinese
益丰药房关于归还部分暂时用于补充流动资金的可转换公司债券募集资金的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by the company Yifeng Pharmacy Chain Co., Ltd. regarding the repayment of part of the temporarily used convertible bond raised funds that were used to supplement working capital. It details specific repayment amounts and dates, references previous announcements, and discusses the balance of funds used. The document is short (1120 characters) and focuses on capital usage and repayment updates related to convertible bonds, which is a financing activity. There is no detailed financial report or comprehensive financial data, nor is it a full annual or interim report. It is not a report publication announcement since it contains substantive information about capital usage and repayments. Therefore, the document fits best under Capital/Financing Update (CAP).
2021-09-24 Chinese
益丰药房关于参加2021年度湖南辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an investor online collective reception day event organized by regulatory bodies and associations. It details the event's date, time, platform, and encourages investor participation. There is no financial data, no report attached or published, and no mention of voting results or management changes. The document is a regulatory announcement related to investor relations and communication, not a financial report or meeting materials. Given the short length and nature of the content, it fits best under Regulatory Filings (RNS).
2021-09-17 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.